azole‐4‐carbaldehyde (28) to afford pyrazolo[3,4‐a]pyrimidines 19–21, 23, 29a, 29b and 30, respectively. Also, the pyrazolopyrimidinone 33 was obtained via treatment of 1 with 1‐cyanoacetyl‐3,5‐dimethylpyrazole (31) followed by cyclization of the formed intermediate 32 with glacial acetic acid. Finally, treatment of 1 with o‐terephthalaldehyde in glacial acetic acid afforded diazepine 34. The newly
4,6-二甲基-1H-
吡唑并[3,4-b]
吡啶-3-胺(1)在与3-(2-
溴乙酰基)-相互作用时用作合成
咪唑并
吡唑衍
生物7-11的关键中间体2H-chromen-2-one (2), 2-(benzothiazol-2-yl)-4-chloro-3-oxobutanenitrile (3), 2,3-dibromonaphthalene-1,4-dione (4), 石脑油[2 ,3-b]oxirene-2,7-dione (5), 2,5-dichloro-3,6-dihydroxyhexa-2,5-diene-1,4-dione (6), 分别。11 乙酰化得到
双乙酰基 12。此外,
咪唑并
嘧啶 15 是通过在
DMF 中用 3,4-二氧代-3,4-二氢
萘-1-
磺酸钠 (13) 处理 1,然后将双-
吡唑并
嘧啶 14 与
冰醋酸。另一方面,化合物 1 与 (E)-1-(4-
甲氧基苯基)-5-